Genome-wide studies of nuclear receptors in cell fate decisions

Seminars in Cell and Developmental Biology

Volumn 24, Issue 10-12, 2013, Pages 706-715

  Mendoza Parra, Marco Antonio ^a   Gronemeyer, Hinrich ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Functional genomics; Nuclear receptors; Retinoic acid receptor; Systems biology

Indexed keywords

CELL NUCLEUS RECEPTOR; HETERODIMER; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA; SPACER DNA; TRANSCRIPTOME;

BINDING SITE; BIOINFORMATICS; CELL DIFFERENTIATION; CELL FATE; CELL METABOLISM; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHROMATIN STRUCTURE; DNA MODIFICATION; EMBRYONAL CARCINOMA STEM CELL; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; PHENOTYPE; PHYSIOLOGICAL PROCESS; REVIEW; RNA SEQUENCE; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TRANSCRIPTION REGULATION;

FUNCTIONAL GENOMICS; NUCLEAR RECEPTORS; RETINOIC ACID RECEPTOR; SYSTEMS BIOLOGY;

ANIMALS; CELL LINEAGE; GENE EXPRESSION REGULATION; GENOME; GENOMICS; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 84888357149     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2013.07.001     Document Type: Review

References (80)

1. Laudet V., Gronemeyer H. The nuclear receptor facts book 2002, Academic Press, San Diego.
2. de Lera A.R., Bourguet W., Altucci L., Gronemeyer H. Design of selective nuclear receptor modulators: RAR and RXR as a case study. Nature Reviews Drug Discovery 2007, 6:811-820.
3. Gronemeyer H., Gustafsson J.A., Laudet V. Principles for modulation of the nuclear receptor superfamily. Nature Reviews Drug Discovery 2004, 3:950-964.
4. Germain P., Chambon P., Eichele G., Evans R.M., Lazar M.A., Leid M., et al. International union of pharmacology. LXIII. Retinoid X receptors. Pharmacological Reviews 2006, 58:760-772.
5. Germain P., Chambon P., Eichele G., Evans R.M., Lazar M.A., Leid M., et al. International union of pharmacology. LX. Retinoic acid receptors. Pharmacological Reviews 2006, 58:712-725.
6. Soprano D.R., Qin P., Soprano K.J. Retinoic acid receptors and cancers. Annual Review of Nutrition 2004, 24:201-221.
7. Altucci L., Gronemeyer H. The promise of retinoids to fight against cancer. Nature Reviews Cancer 2001, 1:181-193.
8. Altucci L., Leibowitz M.D., Ogilvie K.M., de Lera A.R., Gronemeyer H.R.A.R RXR modulation in cancer and metabolic disease. Nature Reviews Drug Discovery 2007, 6:793-810.
9. Bookout A.L., Jeong Y., Downes M., Yu R.T., Evans R.M., Mangelsdorf D.J. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 2006, 126:789-799.
10. Evans R.M., Barish G.D., Wang Y.X. PPARs and the complex journey to obesity. Nature Medicine 2004, 10:355-361.
11. Makishima M., Lu T.T., Xie W., Whitfield G.K., Domoto H., Evans R.M., et al. Vitamin D receptor as an intestinal bile acid sensor. Science 2002, 296:1313-1316.
12. Shulman A.I., Mangelsdorf D.J. Retinoid x receptor heterodimers in the metabolic syndrome. New England Journal of Medicine 2005, 353:604-615.
13. Repa J.J., Mangelsdorf D.J. The liver X receptor gene team: potential new players in atherosclerosis. Nature Medicine 2002, 8:1243-1248.
14. Bourguet W., Germain P., Gronemeyer H. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends in Pharmacological Sciences 2000, 21:381-388.
15. Bourguet W., Ruff M., Chambon P., Gronemeyer H., Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 1995, 375:377-382.
16. Bourguet W., Vivat V., Wurtz J.M., Chambon P., Gronemeyer H., Moras D. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Molecular Cell 2000, 5:289-298.
17. le Maire A., Teyssier C., Erb C., Grimaldi M., Alvarez S., de Lera A.R., et al. A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor. Nature Structural and Molecular Biology 2010, 17:801-807.
18. Wurtz J.M., Bourguet W., Renaud J.P., Vivat V., Chambon P., Moras D., et al. A canonical structure for the ligand-binding domain of nuclear receptors. Natural Structural Biology 1996, 3:206.
19. Rochel N., Ciesielski F., Godet J., Moman E., Roessle M., Peluso-Iltis C., et al. Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings. Nature Structural and Molecular Biology 2011, 18:564-570.
20. Berrabah W., Aumercier P., Lefebvre P., Staels B. Control of nuclear receptor activities in metabolism by post-translational modifications. FEBS Letters 2011, 585:1640-1650.
21. Chen W., Roeder R.G. Mediator-dependent nuclear receptor function. Seminars in Cell and Developmental Biology 2011, 22:749-758.
22. Perissi V., Jepsen K., Glass C.K., Rosenfeld M.G. Deconstructing repression: evolving models of co-repressor action. Nature Reviews Genetics 2010, 11:109-123.
23. Mark M., Ghyselinck N.B., Chambon P. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annual Review of Pharmacology and Toxicology 2006, 46:451-480.
24. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., et al. Estrogen receptors: how do they signal and what are their targets. Physiological Reviews 2007, 87:905-931.
25. York B., Reineke E.L., Sagen J.V., Nikolai B.C., Zhou S., Louet J.F., et al. Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy. Cell Metabolism 2012, 15:752-763.
26. York B., O'Malley B.W. Steroid receptor coactivator (SRC) family: masters of systems biology. Journal of Biological Chemistry 2010, 285:38743-38750.
27. Balmer J.E., Blomhoff R. Gene expression regulation by retinoic acid. Journal of Lipid Research 2002, 43:1773-1808.
28. Harris T.M., Childs G. Global gene expression patterns during differentiation of F9 embryonal carcinoma cells into parietal endoderm. Functional and Integrative Genomics 2002, 2:105-119.
29. Wei Y., Harris T., Childs G. Global gene expression patterns during neural differentiation of P19 embryonic carcinoma cells. Differentiation 2002, 70:204-219.
30. Lyons P. Advances in spotted microarray resources for expression profiling. Briefings in Functional Genomics and Proteomics 2003, 2:21-30.
31. Woods C.G., Heuvel J.P., Rusyn I. Genomic profiling in nuclear receptor-mediated toxicity. Toxicologic Pathology 2007, 35:474-494.
32. Eifert C., Sangster-Guity N., Yu L.M., Chittur S.V., Perez A.V., Tine J.A., et al. Global gene expression profiles associated with retinoic acid-induced differentiation of embryonal carcinoma cells. Molecular Reproduction and Development 2006, 73:796-824.
33. Arima K., Shiotsugu J., Niu R., Khandpur R., Martinez M., Shin Y., et al. Global analysis of RAR-responsive genes in the Xenopus neurula using cDNA microarrays. Developmental Dynamics 2005, 232:414-431.
34. Mamoon A., Ventura-Holman T., Maher J.F., Subauste J.S. Retinoic acid responsive genes in the murine hepatocyte cell line AML 12. Gene 2008, 408:95-103.
35. Chiba H., Clifford J., Metzger D., Chambon P. Specific and redundant functions of retinoid X Receptor/Retinoic acid receptor heterodimers in differentiation, proliferation, and apoptosis of F9 embryonal carcinoma cells. Journal of Cell Biology 1997, 139:735-747.
36. Chiba H., Clifford J., Metzger D., Chambon P. Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells. Molecular and Cellular Biology 1997, 17:3013-3020.
37. Taneja R., Roy B., Plassat J.L., Zusi C.F., Ostrowski J., Reczek P.R., et al. Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RAR beta 2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:6197-6202.
38. Su D., Gudas L.J. Gene expression profiling elucidates a specific role for RARgamma in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells. Biochemical Pharmacology 2008, 75:1129-1160.
39. Laursen K.B., Wong P.M., Gudas L.J. Epigenetic regulation by RARalpha maintains ligand-independent transcriptional activity. Nucleic Acids Research 2012, 40:102-115.
40. Mader S., Chen J.Y., Chen Z., White J., Chambon P., Gronemeyer H. The patterns of binding of RAR, RXR and TR homo- and heterodimers to direct repeats are dictated by the binding specificites of the DNA binding domains. EMBO Journal 1993, 12:5029-5041.
41. Rastinejad F., Perlmann T., Evans R.M., Sigler P.B. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 1995, 375:203-211.
42. Zechel C., Shen X.Q., Chambon P., Gronemeyer H. Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. EMBO Journal 1994, 13:1414-1424.
43. Zechel C., Shen X.Q., Chen J.Y., Chen Z.P., Chambon P., Gronemeyer H. The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO Journal 1994, 13:1425-1433.
44. Huang P., Chandra V., Rastinejad F. Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annual Review of Physiology 2010, 72:247-272.
45. Cotnoir-White D., Laperriere D., Mader S. Evolution of the repertoire of nuclear receptor binding sites in genomes. Molecular and Cellular Endocrinology 2011, 334:76-82.
46. Umesono K., Murakami K.K., Thompson C.C., Evans R.M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 1991, 65:1255-1266.
47. Lalevee S., Anno Y.N., Chatagnon A., Samarut E., Poch O., Laudet V., et al. Genome-wide in silico identification of new conserved and functional retinoic acid receptor response elements (direct repeats separated by 5bp). Journal of Biological Chemistry 2011, 286:33322-33334.
48. Rudert F., Gronemeyer H. Retinoic acid-response elements with a highly repetitive structure isolated by immuno-selection from genomic DNA. Journal of Steroid Biochemistry and Molecular Biology 1993, 46:121-133.
49. Kashyap V., Gudas L.J., Brenet F., Funk P., Viale A., Scandura J.M. Epigenomic reorganization of the clustered Hox genes in embryonic stem cells induced by retinoic acid. Journal of Biological Chemistry 2011, 286:3250-3260.
50. Kashyap V., Gudas L.J. Epigenetic regulatory mechanisms distinguish retinoic acid-mediated transcriptional responses in stem cells and fibroblasts. Journal of Biological Chemistry 2010, 285:14534-14548.
51. Garcia-Bassets I., Kwon Y.S., Telese F., Prefontaine G.G., Hutt K.R., Cheng C.S., et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 2007, 128:505-518.
52. Ross-Innes C.S., Stark R., Holmes K.A., Schmidt D., Spyrou C., Russell R., et al. Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. Genes and Development 2010, 24:171-182.
53. Fadloun A., Kobi D., Delacroix L., Dembele D., Michel I., Lardenois A., et al. Retinoic acid induces TGFbeta-dependent autocrine fibroblast growth. Oncogene 2008, 27:477-489.
54. Delacroix L., Moutier E., Altobelli G., Legras S., Poch O., Choukrallah M.A., et al. Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic fibroblasts and embryonic stem cells. Molecular and Cellular Biology 2010, 30:231-244.
55. Hua S., Kittler R., White K.P. Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell 2009, 137:1259-1271.
56. Mahony S., Mazzoni E.O., McCuine S., Young R.A., Wichterle H., Gifford D.K. Ligand-dependent dynamics of retinoic acid receptor binding during early neurogenesis. Genome Biology 2011, 12:R2.
57. Mendoza-Parra M.A., Walia M., Sankar M., Gronemeyer H. Dissecting the retinoid-induced differentiation of F9 embryonal stem cells by integrative genomics. Molecular Systems Biology 2011, 7.
58. Nielsen R., Pedersen T.A., Hagenbeek D., Moulos P., Siersbaek R., Megens E., et al. Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes and Development 2008, 22:2953-2967.
59. Ceschin D.G., Walia M., Wenk S.S., Duboe C., Gaudon C., Xiao Y., et al. Methylation specifies distinct estrogen-induced binding site repertoires of CBP to chromatin. Genes and Development 2011, 25:1132-1146.
60. Dunham I., Kundaje A., Aldred S.F., Collins P.J., Davis C.A., Doyle F., et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
61. Ernst J., Vainas O., Harbison C.T., Simon I., Bar-Joseph Z. Reconstructing dynamic regulatory maps. Molecular Systems Biology 2007, 3:74.
62. Min I.M., Pietramaggiori G., Kim F.S., Passegue E., Stevenson K.E., Wagers A.J. The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells. Cell Stem Cell 2008, 2:380-391.
63. Orkin S.H., Wang J., Kim J., Chu J., Rao S., Theunissen T.W., et al. The transcriptional network controlling pluripotency in ES cells. Cold Spring Harbor Symposia on Quantitative Biology 2008, 73:195-202.
64. Chaya D., Hayamizu T., Bustin M., Zaret K.S. Transcription factor FoxA (HNF3) on a nucleosome at an enhancer complex in liver chromatin. Journal of Biological Chemistry 2001, 276:44385-44389.
65. Metivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., et al. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115:751-763.
66. Mendoza-Parra M.A., Shankaranarayanan P., Gronemeyer H. Sequential chromatin immunoprecipitation protocol for global analysis through massive parallel sequencing (reChIP-seq). Protocol Exchange 2011, 10.1038/protex.2011.1256.
67. Shankaranarayanan P., Mendoza-Parra M.A., van Gool W., Trindade L.M., Gronemeyer H. Single-tube linear DNA amplification for genome-wide studies using a few thousand cells. Nature Protocols 2012, 7:328-338.
68. Shankaranarayanan P., Mendoza-Parra M.A., Walia M., Wang L., Li N., Trindade L.M., et al. Single-tube linear DNA amplification (LinDA) for robust ChIP-seq. Nature Methods 2011, 8:565-567.
69. Amat R., Gudas L.J. RARgamma is required for correct deposition and removal of Suz12 and H2A. Z in embryonic stem cells. Journal of Cellular Physiology 2010.
70. Gillespie R.F., Gudas L.J. Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells. Journal of Molecular Biology 2007, 372:298-316.
71. Chevillard-Briet M., Trouche D., Vandel L. Control of CBP co-activating activity by arginine methylation. EMBO Journal 2002, 21:5457-5466.
72. Fullwood M.J., Liu M.H., Pan Y.F., Liu J., Xu H., Mohamed Y.B., et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009, 462:58-64.
73. Felsenfeld G., Dekker J. Genome architecture and expression. Current Opinion in Genetics and Development 2012, 22:59-61.
74. van Berkum N.L., Lieberman-Aiden E., Williams L., Imakaev M., Gnirke A., Mirny L.A., et al. Hi-C: a method to study the three-dimensional architecture of genomes. Journal of Visualized Experiments 2010.
75. Kalhor R., Tjong H., Jayathilaka N., Alber F., Chen L. Genome architectures revealed by tethered chromosome conformation capture and population-based modeling. Nature Biotechnology 2012, 30:90-98.
76. Handoko L., Xu H., Li G., Ngan C.Y., Chew E., Schnapp M., et al. CTCF-mediated functional chromatin interactome in pluripotent cells. Nature Genetics 2011, 43:630-638.
77. Li G., Fullwood M.J., Xu H., Mulawadi F.H., Velkov S., Vega V., et al. ChIA-PET tool for comprehensive chromatin interaction analysis with paired-end tag sequencing. Genome Biology 2010, 11:R22.
78. Rickman D.S., Soong T.D., Moss B., Mosquera J.M., Dlabal J., Terry S., et al. Oncogene-mediated alterations in chromatin conformation. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:9083-9088.
79. Schuster-Bockler B., Lehner B. Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature 2012, 488:504-507.
80. Dimitrakopoulou K., Tsimpouris C., Papadopoulos G., Pommerenke C., Wilk E., Sgarbas K.N., et al. Dynamic gene network reconstruction from gene expression data in mice after influenza A (H1N1) infection. Journal of Clinical Bioinformatics 2011, 1:27.